Guangdong True Health Medical Technology Development (HKG:2697) raised HK$384 million in net proceeds from its initial public offering in Hong Kong after pricing the shares below the midpoint of the indicative range.

The surgical robot developer issued 3.56 million shares at HK$126.20 each, less than the HK$127.40 midpoint of the HK$119.30 to HK$135.40 price range, according to a Monday bourse filing.

The Hong Kong public offering portion of the deal was 1,790.4 times subscribed, with 356,480 shares allocated, while the international offering was 2.2 times subscribed, with 3.2 million shares allocated.

True Health Medical is set to debut on the Hong Kong bourse today, June 30.